TerminatedPhase 2NCT01088035

Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma

Studying Ependymoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Principal Investigator
Jason Fangusaro, MD
Ann & Robert H Lurie Children's Hospital of Chicago
Intervention
Carboplatin(drug)
Enrollment
75 enrolled
Eligibility
21 years · All sexes
Timeline
20102015

Study locations (1)

Collaborators

Brown University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01088035 on ClinicalTrials.gov

Other trials for Ependymoma

Additional recruiting or active studies for the same condition.

See all trials for Ependymoma

← Back to all trials